Drug-Induced Impulse Control Disorders: A Prospectus for Neuroethical Analysis

被引:0
|
作者
Adrian Carter
Polly Ambermoon
Wayne D. Hall
机构
[1] The University of Queensland,School of Population Health
[2] The University of Queensland,University of Queensland Centre for Clinical Research
[3] The University of Queensland,Queensland Brain Institute
来源
Neuroethics | 2011年 / 4卷
关键词
Addiction; Neuroethics; Dopamine agonists; Parkinson’s Disease; Impulse control disorders; Moral responsibility;
D O I
暂无
中图分类号
学科分类号
摘要
There is growing evidence that dopamine replacement therapy (DRT) used to treat Parkinson’s Disease can cause compulsive behaviours and impulse control disorders (ICDs), such as pathological gambling, compulsive buying and hypersexuality. Like more familiar drug-based forms of addiction, these iatrogenic disorders can cause significant harm and distress for sufferers and their families. In some cases, people treated with DRT have lost their homes and businesses, or have been prosecuted for criminal sexual behaviours. In this article we first examine the evidence that these disorders are caused by DRT. If it is accepted that DRT cause compulsive or addictive behaviours in a significant minority of individuals, then the following ethical and clinical questions arise: Under what circumstances is it ethical to prescribe a medication that may induce harmful compulsive behaviours? Are individuals treated with DRT morally responsible and hence culpable for harmful or criminal behaviour related to their medication? We conclude with some observations of the relevance of DRT-induced ICDs for our understanding of addiction and identify some promising directions for future research and ethical analysis.
引用
收藏
页码:91 / 102
页数:11
相关论文
共 50 条
  • [1] Drug-Induced Impulse Control Disorders: A Prospectus for Neuroethical Analysis
    Carter, Adrian
    Ambermoon, Polly
    Hall, Wayne D.
    NEUROETHICS, 2011, 4 (02) : 91 - 102
  • [2] Drug-Induced Impulse Control Disorders: A Review
    Atmaca, Murad
    CURRENT CLINICAL PHARMACOLOGY, 2014, 9 (01): : 70 - 74
  • [3] Drug-induced impulse control disorders in Parkinson’s disease
    J. Reiff
    W. H. Jost
    Journal of Neurology, 2011, 258 : 323 - 327
  • [4] Drug-induced impulse control disorders in Parkinson's disease
    Reiff, J.
    Jost, W. H.
    JOURNAL OF NEUROLOGY, 2011, 258 : S323 - S327
  • [5] Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
    Fusaroli, Michele
    Giunchi, Valentina
    Battini, Vera
    Gringeri, Michele
    Rimondini, Roberto
    Menchetti, Marco
    Radice, Sonia
    Pozzi, Marco
    Nobile, Maria
    Clementi, Emilio
    De Ponti, Fabrizio
    Carnovale, Carla
    Raschi, Emanuel
    Poluzzi, Elisabetta
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77 (03) : 160 - 167
  • [6] Drug-induced disorders
    Friedman, M
    AMERICAN FAMILY PHYSICIAN, 1998, 57 (11) : 2615 - 2615
  • [7] Drug-induced disorders
    Holland, EG
    Degruy, FV
    AMERICAN FAMILY PHYSICIAN, 1997, 56 (07) : 1781 - 1788
  • [8] Drug-induced movement disorders
    Zadori, Denes
    Veres, Gabor
    Szalardy, Levente
    Klivenyi, Peter
    Vecsei, Laszlo
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (06) : 877 - 890
  • [9] Drug-induced disorders of the colon
    Neitlich, JD
    Burrell, MI
    ABDOMINAL IMAGING, 1999, 24 (01): : 23 - 28
  • [10] DRUG-INDUCED NEUROLOGICAL DISORDERS
    DICKEY, W
    MORROW, JI
    PROGRESS IN NEUROBIOLOGY, 1990, 34 (04) : 331 - 342